Mirae Asset Global Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-91,204
Closed -$16.8M 1810
2021
Q2
$16.8M Buy
91,204
+19,207
+27% +$3.53M 0.05% 448
2021
Q1
$11M Sell
71,997
-17,029
-19% -$2.6M 0.04% 505
2020
Q4
$13.9M Buy
89,026
+6,278
+8% +$981K 0.05% 399
2020
Q3
$9.47M Buy
82,748
+13,965
+20% +$1.6M 0.05% 401
2020
Q2
$7.72M Buy
68,783
+2,539
+4% +$285K 0.05% 391
2020
Q1
$5.95M Buy
66,244
+17,385
+36% +$1.56M 0.05% 397
2019
Q4
$5.28M Buy
48,859
+6,934
+17% +$750K 0.03% 495
2019
Q3
$4.11M Sell
41,925
-390,533
-90% -$38.2M 0.03% 513
2019
Q2
$56.6M Buy
432,458
+32,374
+8% +$4.24M 0.39% 51
2019
Q1
$54.1M Buy
400,084
+343,285
+604% +$46.4M 0.39% 52
2018
Q4
$5.53M Buy
56,799
+1,917
+3% +$187K 0.05% 347
2018
Q3
$7.62M Buy
54,882
+35,931
+190% +$4.99M 0.06% 327
2018
Q2
$2.33M Sell
18,951
-7,380
-28% -$909K 0.03% 329
2018
Q1
$2.93M Buy
26,331
+10,844
+70% +$1.21M 0.04% 289
2017
Q4
$1.85M Sell
15,487
-47,836
-76% -$5.72M 0.02% 363
2017
Q3
$8.87M Buy
63,323
+19,563
+45% +$2.74M 0.16% 112
2017
Q2
$5.33M Buy
43,760
+14,407
+49% +$1.75M 0.09% 144
2017
Q1
$3.56M Buy
29,353
+12,416
+73% +$1.51M 0.07% 193
2016
Q4
$2.07M Buy
16,937
+2,363
+16% +$289K 0.05% 257
2016
Q3
$1.79M Sell
14,574
-676
-4% -$82.8K 0.04% 257
2016
Q2
$1.78M Sell
15,250
-1,926
-11% -$225K 0.05% 230
2016
Q1
$2.39M Sell
17,176
-8,381
-33% -$1.17M 0.06% 192
2015
Q4
$4.88M Buy
25,557
+1,859
+8% +$355K 0.16% 127
2015
Q3
$3.71M Buy
23,698
+7,326
+45% +$1.15M 0.15% 135
2015
Q2
$2.96M Buy
16,372
+10,285
+169% +$1.86M 0.09% 163
2015
Q1
$1.06M Buy
6,087
+2,053
+51% +$356K 0.04% 292
2014
Q4
$746K Buy
4,034
+520
+15% +$96.2K 0.03% 309
2014
Q3
$583K Buy
+3,514
New +$583K 0.02% 340
2014
Q1
Sell
-9,720
Closed -$1.29M 453
2013
Q4
$1.29M Buy
9,720
+214
+2% +$28.4K 0.05% 237
2013
Q3
$1.1M Sell
9,506
-2,995
-24% -$348K 0.05% 238
2013
Q2
$1.15M Buy
+12,501
New +$1.15M 0.06% 215